Position in VRTX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,605,347
+$262,353 QoQ
Shares Held
5,245
-0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#48
of 250 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $12,066,429 across 29 Biotechnology names. VRTX ranks #1 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,245 | $2,605,347 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,138 | $794,629 | |
| 3 | ARGX |
Argenx SE
|
772 | $716,237 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,054 | $657,210 | |
| 5 | INCY |
Incyte Corp
|
4,816 | $545,940 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,695 | $510,244 | |
| 7 | RPRX |
Royalty Pharma plc
|
9,027 | $506,143 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
6,331 | $495,526 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,605,347 | 5,245 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $2,342,994 | 5,247 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,398,272 | 5,290 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,993,447 | 5,090 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $2,416,544 | 5,428 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $2,829,893 | 5,837 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,251,091 | 5,590 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $2,544,451 | 5,471 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $2,506,713 | 5,348 | Shares | Other | 2024-08-06 | |
| 2024-03-31 | $2,039,051 | 4,878 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,859,079 | 4,569 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1,518,927 | 4,368 | Shares | Other | 2023-10-19 | |
| 2023-06-30 | $1,223,238 | 3,476 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,053,907 | 3,345 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $708,087 | 2,452 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $583,711 | 2,016 | Shares | Other | 2022-10-26 | |
| 2022-06-30 | $426,065 | 1,512 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $360,398 | 1,381 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $364,535 | 1,660 | Shares | Other | 2022-02-14 | |
| 2021-06-30 | $206,266 | 1,023 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $237,883 | 1,107 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $291,879 | 1,235 | Shares | Other | 2021-01-25 | |
| 2020-09-30 | $397,838 | 1,462 | Shares | Other | 2020-10-22 | |
| 2020-06-30 | $419,787 | 1,446 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $355,734 | 1,495 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||